Organon And Co

This study tested three different doses of a hormone-releasing intrauterine device (IUD) against a standard copper IUD for birth control. 84 healthy women who had given birth at least once took part. The goal was to see how safe and acceptable the new IUDs were, and how they affe…

This study looked at whether the etonogestrel birth control implant, which is approved for 3 years, can safely prevent pregnancy for up to 5 years. About 500 women aged 35 or younger who already had the implant for 3 years took part. Researchers tracked pregnancy rates and side e…

This study tested whether adding ezetimibe to the standard cholesterol drug atorvastatin helps very high-risk heart disease patients lower their LDL (bad) cholesterol more effectively. 137 adults with advanced heart disease participated. Results showed that the combination therap…

This study tested a cream called tapinarof for people aged 2 and older with moderate to severe eczema (atopic dermatitis). Over 400 participants used either the study cream or a placebo cream for 8 weeks. The goal was to see if the cream could clear or nearly clear the skin rash.…

This study tested a cream called tapinarof in 407 people aged 2 and older with moderate to severe atopic dermatitis (eczema). The goal was to see if the cream could clear or nearly clear the skin rash and reduce itching after 8 weeks of daily use. Participants were randomly assig…

This study tested a new drug called OG-6219 in 354 women aged 18 to 49 with moderate to severe endometriosis-related pain. The goal was to see if it safely reduces pelvic pain compared to a placebo. The trial is complete, and results will show if this drug can offer a new option …

This study tested a cream called tapinarof in 36 children aged 2 to 17 with moderate-to-severe eczema covering large body areas. The goal was to see how much of the drug enters the body and if it causes side effects. Researchers monitored safety through blood tests, vital signs, …